Standard Biotools Inc - Asset Resilience Ratio

Latest as of September 2025: 36.12%

Standard Biotools Inc (LAB) has an Asset Resilience Ratio of 36.12% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read LAB current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

$194.90 Million

Cash + Short-term Investments

Total Assets

$539.64 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2006–2024)

This chart shows how Standard Biotools Inc's Asset Resilience Ratio has changed over time. See LAB net asset value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Standard Biotools Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Standard Biotools Inc worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$129.42 Million	23.98%
Short-term Investments	$65.48 Million	12.14%
Total Liquid Assets	$194.90 Million	36.12%

Asset Resilience Insights

Very High Liquidity: Standard Biotools Inc maintains exceptional liquid asset reserves at 36.12% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Standard Biotools Inc Industry Peers by Asset Resilience Ratio

Compare Standard Biotools Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
INKON Life Technology Co Ltd SHE:300143	Medical Devices	3.37%
CareRay Digital Medical Technology Co Ltd SHG:688607	Medical Devices	16.21%
Senseonics Holdings, Inc. Common Stock NYSE MKT:SENS	Medical Devices	54.67%
Universus Photo Imagings Limited NSE:UNIVPHOTO	Medical Devices	30.97%
HansBiomed Corporation KQ:042520	Medical Devices	9.13%
Aligned Genetics Inc KQ:238120	Medical Devices	2.22%
Heramed Ltd AU:HMD	Medical Devices	0.83%
Acarix A/S ST:ACARIX	Medical Devices	37.81%

Annual Asset Resilience Ratio for Standard Biotools Inc (2006–2024)

The table below shows the annual Asset Resilience Ratio data for Standard Biotools Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	20.60%	$126.15 Million	$612.34 Million	+1.04pp
2023-12-31	19.56%	$63.19 Million	$323.07 Million	-22.92pp
2022-12-31	42.47%	$165.78 Million	$390.31 Million	+32.14pp
2021-12-31	10.34%	$28.45 Million	$275.21 Million	+3.96pp
2020-12-31	6.37%	$20.70 Million	$324.76 Million	-9.50pp
2019-12-31	15.87%	$42.02 Million	$264.81 Million	-9.72pp
2018-12-31	25.59%	$77.72 Million	$303.65 Million	+10.63pp
2017-12-31	14.97%	$43.01 Million	$287.35 Million	+0.13pp
2016-12-31	14.83%	$45.45 Million	$306.39 Million	-2.92pp
2015-12-31	17.75%	$65.86 Million	$371.06 Million	-2.27pp
2014-12-31	20.02%	$81.59 Million	$407.56 Million	-21.96pp
2013-12-31	41.98%	$49.08 Million	$116.92 Million	+23.20pp
2012-12-31	18.78%	$21.36 Million	$113.73 Million	-31.53pp
2011-12-31	50.32%	$39.91 Million	$79.33 Million	+38.84pp
2007-12-31	11.48%	$6.29 Million	$54.78 Million	+10.11pp
2006-12-31	1.37%	$500.00K	$36.49 Million	--

pp = percentage points

About Standard Biotools Inc

NASDAQ:LAB USA Medical Devices

Market Cap

$361.49 Million

Market Cap Rank

#14166 Global

#3206 in USA

Share Price

$0.94

Change (1 day)

+1.22%

52-Week Range

$0.88 - $1.68

All Time High

$14.36